Clinical trial
Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic…
NCT00431431 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00431431 |
|---|---|
| Title | Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) |
| Official title | A Multinational, Randomized, Double-Blind, Parallel Group Comparative Trial on the Effects of 2 Years Treatment With Tibolone (1.25 mg Org OD 14) and Raloxifene (60 mg) on Bone Mineral Density in Osteopenic Postmenopausal Women |
| Acronym | STEP |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteopenia |
| Intervention type | Drug |
| Interventions | tibolone, raloxifen |
| Enrollment | 324 |
| Start date | Jul 31, 2000 |
| Primary completion | Feb 15, 2005 |
| Completion | Feb 15, 2005 |
| First posted | Feb 5, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: